Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Transplantation immunology in 2013

New approaches to diagnosis of rejection

In 2013, a key theme of research in renal transplantation was the diagnosis of rejection. Data from key studies published in the past year highlight aspects of rejection that warrant further investigation and should prompt the consideration of adjunctive tests to complement traditional histological assessment of allograft biopsy samples.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Reeve, J. et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am. J. Transplant. 13, 645–655 (2013).

    Article  CAS  PubMed  Google Scholar 

  2. Sellarés, J. et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am. J. Transplant. 13, 971–983 (2013).

    Article  PubMed  Google Scholar 

  3. Halloran, P. F. et al. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am. J. Transplant. 13, 2352–2363 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am. J. Transplant. 13, 2865–2874 (2013).

    Article  CAS  PubMed  Google Scholar 

  5. Furness, P. N. et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am. J. Surg. Path. 27, 805–810 (2003).

    Article  PubMed  Google Scholar 

  6. Mengel, M. et al. Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts. Am. J. Transplant. 13, 1235–1245 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Lefaucheur, C. et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 381, 313–319 (2013).

    Article  CAS  PubMed  Google Scholar 

  8. Suthanthiran, M. et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N. Engl. J. Med. 369, 20–31 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ingelfinger, J. R. & Alexander, S. I. One step closer to “Rejectostix.” N. Engl. J. Med. 369, 84–85 (2013).

    Article  CAS  PubMed  Google Scholar 

  10. Loupy, A. et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N. Engl. J. Med. 369, 1215–1226 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

N. A. Zwang thanks the Brigham and Women's Hospital/Massachusetts General Hospital Joint Nephrology Fellowship Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas A. Zwang.

Ethics declarations

Competing interests

L. A. Turka is married to an employee of Novartis. N. A. Zwang declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zwang, N., Turka, L. New approaches to diagnosis of rejection. Nat Rev Nephrol 10, 72–74 (2014). https://doi.org/10.1038/nrneph.2013.262

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.262

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing